We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
-3.68%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$336M
AUM Growth
-$64.6M
Cap. Flow
-$15.1M
Cap. Flow %
-4.5%
Top 10 Hldgs %
79.42%
Holding
82
New
2
Increased
7
Reduced
6
Closed
7
Avg Time Held
2.8 years
Top 10 Avg Time Held
2.5 years
Top 20 Avg Time Held
2.2 years

Top Buys

Rank Stock Value
1
GPGI icon
GPGI Inc
GPGI
+$5.32M
2
TALK icon
Talkspace
TALK
+$2.16M
3
MSAI icon
MultiSensor AI
MSAI
+$1.98M
4
PROK icon
ProKidney
PROK
+$1.64M
5
DMAC icon
DiaMedica Therapeutics
DMAC
+$439K

Sector Composition

Rank Sector Weight
1 Miscellaneous 30.95%
2 Industrials 18.39%
3 Healthcare 14.98%
4 Materials 11.89%
5 Financials 11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CDNS icon
51
Cadence Design Systems
CDNS
$88.6B
$162K 0.05%
525
– –
2020 Q2
16 quarters
ARKOW icon
52
DELISTED
ARKO Corp Warrant
ARKOW
$159K 0.05%
333,333
– –
2020 Q4
14 quarters
AMD icon
53
Advanced Micro Devices
AMD
$893B
$148K 0.04%
913
– –
2022 Q1
9 quarters
LGF.B
54
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$141K 0.04%
16,413
– –
2019 Q4
18 quarters
MOVE icon
55
Corvex Inc
MOVE
$250M
$129K 0.04%
+4,246
New +$204K
2024 Q2
0 quarters
XOM icon
56
ExxonMobil
XOM
$719B
$124K 0.04%
1,075
– –
2020 Q2
16 quarters
BNY icon
57
Bank of New York Mellon
BNY
$96.3B
$120K 0.04%
2,000
– –
2020 Q1
17 quarters
RGF icon
58
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
$100K 0.03%
16,667
– –
2023 Q4
2 quarters
TER icon
59
Teradyne
TER
$52.4B
$89K 0.03%
600
– –
2020 Q2
16 quarters
LILAK icon
60
Liberty Latin America Class C
LILAK
$1.61B
$79.5K 0.02%
9,087
-9,087
-50% -$67.8K
2020 Q2
16 quarters
CMPOW icon
61
DELISTED
CompoSecure Inc Warrant
CMPOW
$44.5K 0.01%
100,000
– –
2022 Q1
9 quarters
LITE icon
62
Lumentum
LITE
$76.6B
$33.6K 0.01%
660
– –
2020 Q2
16 quarters
ARKF icon
63
ARK Blockchain & Fintech Innovation ETF
ARKF
$896M
$33.4K 0.01%
1,200
– –
2022 Q1
9 quarters
OPFI.WS icon
64
DELISTED
OppFi Inc Warrants
OPFI.WS
$32.5K 0.01%
250,000
– –
2021 Q3
11 quarters
ARKW icon
65
ARK Next Generation Technology ETF
ARKW
$2.21B
$23.4K 0.01%
300
– –
2022 Q1
9 quarters
RVMD icon
66
Revolution Medicines
RVMD
$40.9B
$21.6K 0.01%
556
– –
2023 Q4
2 quarters
RVMDW icon
67
Revolution Medicines Inc Warrant
RVMDW
$108M
$20.4K 0.01%
200,000
– –
2023 Q4
2 quarters
ARKG icon
68
ARK Genomic Revolution ETF
ARKG
$2.07B
$19.4K 0.01%
825
– –
2022 Q1
9 quarters
LILA icon
69
Liberty Latin America Class A
LILA
$1.62B
$19.3K 0.01%
2,957
-2,956
-50% -$16.5K
2020 Q1
17 quarters
AENTW icon
70
Alliance Entertainment Holding Corp Warrants
AENTW
$14K ﹤0.01%
200,000
– –
2023 Q2
4 quarters
XFOR icon
71
X4 Pharmaceuticals
XFOR
$256M
$10.4K ﹤0.01%
596
– –
2019 Q4
18 quarters
WGS icon
72
GeneDx Holdings
WGS
$2.12B
$7.95K ﹤0.01%
304
– –
2021 Q3
11 quarters
SVREW icon
73
SaverOne 2014 Ltd Warrant
SVREW
$7.55K ﹤0.01%
121,000
– –
2022 Q2
8 quarters
AVNW icon
74
Aviat Networks
AVNW
$251M
$1.89K ﹤0.01%
66
– –
2020 Q2
16 quarters
ASTR icon
75
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$260 ﹤0.01%
517
– –
2021 Q3
11 quarters

Similar funds

Bleichroeder LP's Q2 2024 Portfolio in Review

As of Q2 2024, Bleichroeder LP held 82 positions worth $336M, down 16% from $401M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Bleichroeder LP withdrew a net $15.1M in Q2 2024, closing 7 positions and reducing 6 holdings. Its most notable exit was Insmed, an estimated $8.82M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 31% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Bleichroeder LP opened a new position in MultiSensor AI worth $1.33M.

  • Bleichroeder LP's largest Q2 2024 buy was MultiSensor AI: 20,200 shares worth $1.33M.
  • Bleichroeder LP added most to GPGI Inc in Q2 2024, an estimated $5.32M increase.
  • Bleichroeder LP's biggest Q2 2024 reduction was Brunswick, cutting an estimated $14.3M.
  • Bleichroeder LP fully exited Insmed in Q2 2024, selling an estimated $8.82M.
  • Bleichroeder LP's ten largest holdings make up 79% of its $336M portfolio in Q2 2024.
  • Bleichroeder LP opened 2 new positions and closed 7 in Q2 2024.
  • Bleichroeder LP's portfolio value fell 16% quarter-over-quarter to $336M.

Based on Bleichroeder LP's 13F filing for Q2 2024, filed 13 Aug 2024.